Title of the cohort

Utilisation and costs of health and nursing services for elderly patients with multimorbidity in the German Statutory Health Insurance System – a observational cohort study

Acronym for cohort


Name of Principal Investigator
TitleProf. Dr.
First name Hendrik
Last namevan den Bussche
Address of institution where award is held
InstitutionDepartment of Primary Medical Care, University Medical Center Hamburg-Eppendorf
Street AddressMartinistr. 52




Contact email
Funding source


1. The cohort includes, or expects to include, incidence of the following conditions
  • Alzheimer’s disease and other dementias
  • Parkinson’s disease
When studies on the above condition(s) are expected to become possible

Already possible

2a. Stated aim of the cohort

Analysis of medical and nursing services utilized by elderly patients with multimorbidity, estimation of costs of services of statutory medical and nursing care for elderly patients with multimorbidity

2b. Features distinguishing this cohort from other population cohorts
3a. i) Number of publications that involve use of cohort to date
3a. ii) Up to three examples of studies to date (PI, Institution, Title of Study)
3b. Publication list/link to where data or publications are accessible (if available)
3c. Information (i.e. research findings) expected to be gained from the population cohort
4a. Study criteria: age range of participants at recruitment
Age in years from:65
To (‘until death’ if applicable):until death
4b. Study criteria: inclusion criteria
4c. Study criteria: exclusion criteria

1. incompletely insured in the year 2004, 2. patients over 100 years, who did not consult any physician within 2004

5. Size of the cohort (i.e. number of participants enrolled)

More than 15,000

6a. Measures used to characterise participants

Age, gender, morbidity, nursing dependency, ambulatory services, inpatient services, therapeutic measures, medical equipment, surgical appliances, medication, costs, mortality

6b. Additional measures for participants with a clinical disorder
6c. Are there defined primary and secondary endpoints (e.g. defined health parameters)


7. Study design

Prospective cohort

8. Cases matched by
  • Other health assessment (specify) / N/A
  • no matching
9a. Does the study include a specialised subset of control participants


9b. If yes, description of specialised subset of control participants
10a. i) Data collection start date


10a. ii) Data collection end date
10a iii) Data collection for this study is
  • Data collection ongoing
  • Data analysis ongoing
10b. Plans to continue the cohort study beyond the current projected end date
  • Yes – intend to apply for funding
11. Data collected
12. System in place to enable re-contact with patients for future studies
13a. Format and availability of data stored in a database
Language used:
13b. Format and availability of data held as individual records
Language used:
14a. Are data available to other groups


14b. Access policy/mechanisms for access if data are available to other groups
15. Data sharing policy specified as a condition of use

No policy exists

16a. Are tissues/samples/DNA available to other groups


16b. i) Description of available tissues/samples/DNA
16b. ii) Form available tissues/samples/DNA are supplied in
16b. iii) Is the access policy/mechanism for obtaining samples the same as that for obtaining data
17. Is information on biological characteristics available to other groups
  • No

    Types: Population Cohorts
    Member States: Germany
    Diseases: Alzheimer's disease & other dementias, Parkinson's disease & PD-related disorders
    Years: N/A
    Database Categories: N/A
    Database Tags: N/A

    Export as PDF